Total Payments
$246,857
2023 Payments
$52.81
Companies
45
Transactions
721
Medicare Patients
6,190
Medicare Billing
$770,462
Payment Breakdown by Category
Other$205,788 (83.4%)
Food & Beverage$14,771 (6.0%)
Consulting$13,774 (5.6%)
Travel$12,480 (5.1%)
Gifts$27.78 (0.0%)
Education$16.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $205,788 | 108 | 83.4% |
| Food and Beverage | $14,771 | 547 | 6.0% |
| Consulting Fee | $13,774 | 14 | 5.6% |
| Travel and Lodging | $12,480 | 50 | 5.1% |
| Gift | $27.78 | 1 | 0.0% |
| Education | $16.24 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $92,807 | 93 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $76,462 | 160 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $59,448 | 68 | $0 (2022) |
| Boston Scientific Corporation | $8,987 | 27 | $0 (2018) |
| Ethicon Inc. | $962.48 | 9 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $921.87 | 49 | $0 (2022) |
| Veran Medical Technologies, Inc. | $858.98 | 5 | $0 (2020) |
| Pulmonx Corporation | $804.83 | 5 | $0 (2022) |
| GlaxoSmithKline, LLC. | $797.40 | 53 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $525.53 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $52.81 | 1 | GlaxoSmithKline, LLC. ($52.81) |
| 2022 | $39,975 | 84 | GENZYME CORPORATION ($30,695) |
| 2021 | $83,059 | 149 | GENZYME CORPORATION ($29,877) |
| 2020 | $38,066 | 87 | AstraZeneca Pharmaceuticals LP ($12,945) |
| 2019 | $44,775 | 146 | GENZYME CORPORATION ($20,012) |
| 2018 | $12,597 | 111 | AstraZeneca Pharmaceuticals LP ($7,862) |
| 2017 | $28,332 | 143 | AstraZeneca Pharmaceuticals LP ($20,768) |
All Payment Transactions
721 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $52.81 | General |
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $988.81 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $988.78 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $228.75 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $189.75 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $189.75 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $171.25 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $64.82 | General |
| Category: Immunology | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.26 | General |
| Category: Immunology | ||||||
| 06/23/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Immunology | ||||||
| 06/16/2022 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: NEUROLOGY | ||||||
| 06/15/2022 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Cardiology | ||||||
| 06/13/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Respiratory | ||||||
| 06/06/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/27/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
| 05/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Hematology | ||||||
| 05/24/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2022 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Sleep | ||||||
| 05/14/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: IMMUNOLOGY | ||||||
| 05/05/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/05/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $221.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/04/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Immunology | ||||||
| 05/04/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,012.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 204 | 293 | $110,471 | $30,113 |
| 2022 | 21 | 1,482 | 2,368 | $616,964 | $197,666 |
| 2021 | 24 | 2,267 | 3,292 | $886,171 | $299,741 |
| 2020 | 25 | 2,237 | 2,985 | $704,919 | $242,941 |
Total Patients
6,190
Total Services
8,938
Medicare Billing
$770,462
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 35 | 63 | $60,430 | $10,969 | 18.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 105 | $28,191 | $9,688 | 34.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 89 | $11,950 | $5,672 | 47.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 36 | 36 | $9,900 | $3,784 | 38.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 207 | 410 | $87,891 | $33,070 | 37.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 198 | 514 | $67,160 | $29,192 | 43.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 60 | 135 | $117,225 | $22,685 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 240 | $45,600 | $21,398 | 46.9% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 34 | 34 | $50,660 | $15,838 | 31.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 144 | 149 | $40,975 | $15,762 | 38.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 29 | 30 | $49,200 | $14,288 | 29.0% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 42 | 253 | $27,640 | $13,275 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 134 | $20,880 | $6,441 | 30.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $9,805 | $4,256 | 43.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $9,103 | $3,321 | 36.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 70 | 70 | $10,500 | $3,014 | 28.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 67 | 67 | $14,070 | $2,633 | 18.7% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 33 | 33 | $14,850 | $2,426 | 16.3% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 24 | 24 | $6,360 | $2,385 | 37.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 20 | 35 | $4,940 | $2,373 | 48.0% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2022 | 16 | 17 | $9,350 | $1,790 | 19.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 78 | 78 | $7,410 | $1,456 | 19.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 34 | 35 | $3,325 | $741.87 | 22.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 27 | 28 | $16,800 | $670.31 | 4.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 23 | 23 | $3,220 | $649.86 | 20.2% |
About Dr. Tabarak Qureshi, MD
Dr. Tabarak Qureshi, MD is a Critical Care Medicine healthcare provider based in Altamonte Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1962674549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tabarak Qureshi, MD has received a total of $246,857 in payments from pharmaceutical and medical device companies, with $52.81 received in 2023. These payments were reported across 721 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($205,788).
As a Medicare-enrolled provider, Qureshi has provided services to 6,190 Medicare beneficiaries, totaling 8,938 services with total Medicare billing of $770,462. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Altamonte Springs, FL
- Active Since 03/24/2008
- Last Updated 12/01/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1962674549
Products in Payments
- DUPIXENT (Biological) $132,173
- BEVESPI AEROSPHERE (Drug) $23,070
- BREZTRI (Drug) $22,859
- DUPIXENT (Drug) $20,042
- FASENRA (Drug) $17,075
- BREZTRI AEROSPHERE (Drug) $7,507
- ALAIR (Device) $6,954
- FASENRA (Biological) $2,810
- SYMBICORT (Drug) $1,403
- TAGRISSO (Drug) $1,269
- Monarch Platform (Device) $962.48
- GENERAL BRONCHIAL THERMOPLASTY (Device) $868.66
- Spin (Device) $858.98
- GENERAL PULMONARY (Device) $800.00
- Pulmonx Endobronchial Valve EBV (Device) $784.40
- UPTRAVI (Drug) $689.72
- XOLAIR (Biological) $440.79
- NUCALA (Biological) $363.30
- Wakix (Drug) $244.18
- OFEV (Drug) $235.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.